Literature DB >> 11316762

Receptor-operated osteoclast calcium sensing.

B D Bennett1, U Alvarez, K A Hruska.   

Abstract

Osteoclasts "sense" elevated extracellular calcium, which leads to cytoskeletal changes that may be linked to phospholipase C (PLC) activation and the associated rise in intracellular calcium ([Ca(2+)](i)). Since PLC is linked to transient receptor potential channels (trp), we hypothesized that receptor activated calcium influx due to this channel type would be activated by osteoclasts sensing [Ca(2+)](e). We found that high [Ca(2+)](e) induced similar intracellular Ca(2+) rises in chicken osteoclasts with or without intracellular Ca(2+) store depletion by either TPEN or thapsigargin, thus defining store-insensitive Ca(2+) influx. This store-insensitive calcium sensing component was blocked by the PLC antagonist U73122. Also, the calcium channel inhibitor SKF 96365, a blocker of store-independent trp-like channels, was effective in inhibiting calcium sensing in the presence of thapsigargin. Thus, a store-independent component of calcium sensing was associated with ion channels linked to PLC. Since receptor activated transient receptor potential (trp) family cation channels open in a PLC-dependent and store-independent manner, we suggest that receptor operated channels are activated in osteoclasts stimulated by high extracellular Ca(2+).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316762     DOI: 10.1210/endo.142.5.8125

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Regulation of osteoclast polarization.

Authors:  Naoyuki Takahashi; Sadakazu Ejiri; Shigeru Yanagisawa; Hidehiro Ozawa
Journal:  Odontology       Date:  2007-07-25       Impact factor: 2.634

Review 2.  Cooperative electrogenic proton transport pathways in the plasma membrane of the proton-secreting osteoclast.

Authors:  Miyuki Kuno
Journal:  Pflugers Arch       Date:  2018-03-17       Impact factor: 3.657

Review 3.  The calcium-sensing receptor in bone metabolism: from bench to bedside and back.

Authors:  L Cianferotti; A R Gomes; S Fabbri; A Tanini; M L Brandi
Journal:  Osteoporos Int       Date:  2015-06-23       Impact factor: 4.507

4.  TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption.

Authors:  Estelle Chamoux; Martine Bisson; Marcel Daniel Payet; Sophie Roux
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

Review 5.  Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.

Authors:  Christian Santa Maria; Zhiqiang Cheng; Alfred Li; Jiali Wang; Dolores Shoback; Chia-Ling Tu; Wenhan Chang
Journal:  Semin Cell Dev Biol       Date:  2015-12-10       Impact factor: 7.727

6.  pH dependence and inhibition by extracellular calcium of proton currents via plasmalemmal vacuolar-type H+-ATPase in murine osteoclasts.

Authors:  Hiromu Sakai; Junko Kawawaki; Yoshie Moriura; Hiroyuki Mori; Hirokazu Morihata; Miyuki Kuno
Journal:  J Physiol       Date:  2006-08-10       Impact factor: 5.182

7.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

Review 8.  Calcium signalling and calcium transport in bone disease.

Authors:  H C Blair; P H Schlesinger; C L H Huang; M Zaidi
Journal:  Subcell Biochem       Date:  2007

9.  Hormone-stimulated modulation of endocytic trafficking in osteoclasts.

Authors:  Gudrun Stenbeck; Kevin M Lawrence; Anthony P Albert
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-22       Impact factor: 5.555

Review 10.  Ca(2+) channels on the move.

Authors:  Colin W Taylor; David L Prole; Taufiq Rahman
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.